NSEGeneral Updates18 Jun 2026 · 18 Jun 2026, 10:43 pm
General Updates
Camlin Fine Sciences Limited · CAMLINFINE
✦ AI SummaryRegulatory
Camlin Fine Sciences Limited has informed the Exchange about a press release issued by the Company regarding the clearance decision of the French stock market authority for the mandatory tender offer by the Company for Vinpai shares, along with the release of the offer document and other information document.
Analysis Scores
Earnings Impact5/10
Growth Catalyst3/10
Governance Concern2/10
Regulatory Risk8/10
Balance Sheet Risk4/10
Liquidity Impact6/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Camlin Fine Sciences Limited has informed the Exchange about Press Release issued by the Company.
Attachments (1)
📄pdf
Download →
CAMLINFINE_18062026223919_CSFL_SE_Intimation_18062026.pdf
View document text
June 18, 2026
To, To,
BSE Limited, The Manager,
25, P. J. Towers, Listing Department,
Dalal Street, National Stock Exchange of India Ltd.,
Mumbai – 400 001 Exchange Plaza, Bandra Kurla Complex,
Ref: Company Scrip Code: 532834 Bandra (East), Mumbai‐ 400051
Ref: Symbol: CAMLINFINE || Series: EQ
Sub: Disclosure pursuant to the Regulation 30 read with Schedule III of SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015 (the 'Listing Regulations')
Dear Sir/Madam,
Further to our earlier press releases regarding the acquisition of the remaining shares of Vinpai (ISIN:
FR001400AXT1; mnémonique: ALVIN) on Euronext Growth Paris, we wish to inform you that the Company
has today issued the enclosed press release on Euronext Growth Paris in relation to the clearance decision
of the French stock market authority for the mandatory tender offer by the Company for Vinpai shares,
along with the release of the offer document and other information document.
Kindly take the same on your records.
Thanking You,
For Camlin Fine Sciences Limited
Rahul Sawale
Company Secretary
& VP Legal
Encl.: a/a.
This press release must not be published, distributed or transmitted, directly or indirectly, in the United States
of America, Australia, Canada, South Africa or Japan.
Press release
French stock market authority clearance decision
regarding the mandatory tender offer by CAMLIN
FINE SCIENCES on Vinpai shares
Release of the offer document and other information
document
Mumbai (India), June 18, 2026 – 18 h CET
CAMLIN FINE SCIENCES LIMITED, a leading Indian group in shelf life solutions for flavour and health
& wellness ingredients, listed on the National Stock Exchange of India Ltd and BSE Ltd. in Mumbai
India (“CFSL”) reminds that it has completed the acquisition on November 27, 2025, by way of
contribution in kind, of a majority stake in the share capital of Vinpai (ISIN: FR001400AXT1;
mnémonique : ALVIN) representing 78.68% of share capital and 84.89% of voting rights of Vinpai, at
a price of EUR 3.60 per Vinpai share (the “Block Acquisition”) from majority shareholders (the
“Sellers”) and proceeded to the conversion of the convertible bonds (the “Convertible Bonds”),
allowing it to subscribe to 1,100,000 new ordinary shares of Vinpai, that were issued to it.1
As of today, CFSL holds 83.82% of Vinpai's share capital and 80.85% of its voting rights.
CFSL announces that the board of the French Stock Markets Authority (AMF) has issued today its
clearance decision on the simplified cash tender offer share capital (offre publique d’achat simplifiée)
(the “OPAS”) for the remaining shares of Vinpai’s share capital that are not held by CFSL, at the same
price as that of the Block Acquisition, i.e. EUR 3.60 per Vinpai share.
The timetable and the terms and conditions of the OPAS are detailed in the offer document of CFSL
(the “Offer Document”).
In accordance with Article 231-28 of the AMF General Regulation, information relating in particular to
the legal, financial and accounting characteristics of CFSL (the “Other Information Document”),
together with the Offer Document, have been made available to the public today available on the
websites of the AMF (www.amf-france.org), of Camlin Fine Sciences Limited (www.camlinfs.com/) and
of Vinpai (https://vinpai-finance.com/fr/).
Advisors of CFSL :
Presenting institution Legal Advisor
FONTAINE
AVOCATS
1 Cf : Press release of Vinpai on October 20, 2025
EUI-3401903934v3
For further information about CFSL: www.camlinfs.com
Contacts
Camlin Fine Sciences Limited
Relations investisseurs
corporate@camlinfs.com
T.: +91 22 6700 1000 -Ext. 402
Disclaimer
This press release does not constitute an offer to sell nor a solicitation of an offer to buy Vinpai shares in any country,
nor shall there be any sale of shares in any state or jurisdiction in which such an offer, solicitation or sale would be
unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
The distribution of this document may, in certain jurisdictions, be restricted by local legislations. Persons into
whose possession this document comes are required to inform themselves about and to observe any such
potential local restrictions.
This press release constitutes an advertisement and not a prospectus within the meaning of Regulation (EU) no.
2017/1129 of the European Parliament and of the Council of June 14, 2017 (the “Prospectus Regulation”). Any
decision to purchase shares must be made solely on the basis of publicly available information on the Company.
In France, the issue of bonds convertible into Vinpai shares described above was reserved to an investor falling into
the category of beneficiaries defined in the sixteenth resolution of the Company’s general meeting dated June 26,
2024, pursuant to article L. 228-91 of the French commercial code and applicable regulatory provisions. Pursuant
to article 211-3 of the French stock market authority (Autorité des marchés financiers) (the “AMF”) general
regulations and articles 1(4) and 3 of the Prospectus Regulation, the said issue of convertible bonds will not require
the publication of a prospectus approved by the AMF.
With respect to Member States of the European Economic Area, no action has been taken or will be taken to
permit a public offering of the securities referred to in this press release requiring the publication of a prospectus
in any Member State. Therefore, such securities may not be and shall not be offered in any Member State other
than in accordance with the exemptions of article 1(4) of the Prospectus Regulation or, otherwise, in cases not
requiring the publication by the Company of a prospectus under article 3 of the Prospectus Regulation and/or the
applicable regulations in such Member State.
This press release and the information it contains are being distributed to and are only intended for persons who
are (x) outside the United Kingdom or (y) in the United Kingdom, who constitute “qualified investors” (as this term
is defined in the Prospectus Regulation which forms part of domestic law pursuant to European (Withdrawal) Act
2018) and are (i) investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000
(Financial Promotion) Order 2005, as amended (the “Order”), (ii) high net worth entities and other such persons
falling within Article 49(2)(a) to (d) of the Order (“high net worth companies”, “unincorporated associations”, etc.)
or (iii) other persons to whom an invitation or inducement to participate in investment activity (within the meaning
of Section 21 of the Financial Services and Market Act 2000) may otherwise lawfully be communicated or caused
to be communicated (all such persons in (y)(i), (y)(ii) and (y)(iii) together being referred to as “Relevant Persons”).
Any invitation, offer or agreement to subscribe, purchase or otherwise acquire securities to which this press release
relates will only be available to and engaged with Relevant Persons. This press release is solely intended for
Relevant Persons and any person who is not a Relevant Person should not act or rely on this press release or any
of its contents.
This press release and the information contained therein does not, and will not, constitute an offer of securities for
sale, nor the solicitation of an offer to purchase, Vinpai securities in the United States of America or any other
jurisdiction where restrictions may apply. Securities may not be offered or sold in the United States of America
absent registration or an exemption from registration under the U.S. Securities Act of 1933, as amended (the
“Securities Act”). The securities of Vinpai have not been and will not be registered under the Securities Act, and
the Company does not intend to conduct a public offering of Vinpai securities in the United States of America.
EUI-3401903934v3
The distribution of this press release may be subject to legal or regulatory restrictions in certain juris
[Showing first 8,000 characters — download PDF for full document]